Form 4 for AURA Aura Biosciences, Inc.
Accepted 2025-05-20 00:00:00 ET · period of report 2025-05-16 · accession 0000950170-25-075403 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-20 | 2025-05-16 | AURA | Gibney Anthony S | See Remarks | P - Purchase | $4.90 | +50.0K | 58.5K | +592% | +$245.0K |
| D | 2025-05-20 | 2025-05-16 | AURA | Gibney Anthony S | See Remarks | S - Sale | $5.15 | -1,519 | 56.9K | -3% | -$7,823 |
| D | 2025-05-20 | 2025-05-16 | AURA | Gibney Anthony S | See Remarks | P - Purchase | — | +12.5K | 12.5K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-16 | P | A | 50,000 | $4.90 | 58,452 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-16 | S | D | 1,519 | $5.15 | 56,933 | D | — | — | |
| 3 | Derivative | Common Stock Warrants (right to buy) | 2025-05-16 | P | A | 12,500 | — | 12,500 | D | $4.90 · 2025-05-16 to 2030-05-16 | 12,500 Common Stock | (F1) On May 16, 2025, the Reporting Person purchased 50,000 shares of the Issuer's common stock and a warrant to purchase 12,500 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering. |